ARCHIVES

FDA to refer false statements by regulated companies to SEC.

This article is from The Cancer Letter archive.

Vol. 30 No. 09 | February 27, 2004

Download PDF Visit The Full Archive

Related Articles

Howard Hughes Medical Institute Appoints 12 Physician Investigators

May 31, 2002

Palmetto Establishes Coverage For Thyroid Genomic Test

January 27, 2012

National Action Plan: Steering committee Votes No Confidence In HHS Official.

August 15, 1997

Liver Transplant Associated With 67% 5-Year Survival

February 23, 2007

FDA: If Carboplatin Dose Is Based On Actual GFR Measurements, Package Insert Dosing Instructions Accurate

October 8, 2010

Radiation Oncologist Objects To ACR Comments Results

November 27, 1981